DiagnoCure, Inc.

DiagnoCure, Inc.

Sector: Testing Laboratories Region: Canada

: | Toronto Stock Exchange: CUR | OTC Markets: DGCRF

DiagnoCure, Inc. is a biotechnology company, which develops and commercializes cancer diagnostic tests. It intends to continue its research and development and marketing efforts. Its offerings include prostate, colorectal, previstage GCC, lung and diagnostic test and other research and development services. The company was founded by Yves Fradet on December 8, 1994 and is headquartered in Québec, Canada.

News & Analysis

You may also be interested in: